Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000905148-21-000683
Filing Date
2021-10-22
Accepted
2021-10-21 18:52:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 efc21-572_sc13d.htm SC 13D 57757
  Complete submission text file 0000905148-21-000683.txt   59054
Mailing Address C/O REXAHN PHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address
Sullivan Lara (Filed by) CIK: 0001769457 (see all company filings)

Type: SC 13D

Mailing Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199
Business Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199 (617) 351-2575
Pyxis Oncology, Inc. (Subject) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92951 | Film No.: 211338225
SIC: 2834 Pharmaceutical Preparations